This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Inventor Hannah Dexter
Introduction
Hannah Dexter is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific biological pathways.
Latest Patents
Hannah holds 1 patent for her work on Nicotinamide RIPK1 inhibitors. This patent includes compounds of Formula (I) and pharmaceutically acceptable salts that are useful as RIPK1 inhibitors. The patent also details pharmaceutical compositions comprising these compounds and methods for their use and preparation. Additionally, it outlines methods for treating Ulcerative Colitis using a compound of Formula (I).
Career Highlights
Hannah Dexter is currently employed at AbbVie Inc., where she continues to innovate in the pharmaceutical sector. Her work focuses on developing new therapeutic options that can improve patient outcomes.
Collaborations
Throughout her career, Hannah has collaborated with notable colleagues, including Euan Fordyce and Kevin Patrick Cusack. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Hannah Dexter's innovative work in the field of pharmaceuticals, particularly her patent on Nicotinamide RIPK1 inhibitors, showcases her dedication to improving healthcare solutions. Her contributions are significant and reflect her commitment to advancing medical science.